453 records matched your query
03406aam a2200529 i 4500 001 5FEB261EE9E911EBBBC9467A3DECA4DB 003 SILO 005 20210721010052 008 181113s2018 ne b 001 0 eng 010 $a 2018298941 020 $a 9403501138 020 $a 9789403501130 035 $a (OCoLC)1050133816 040 $a DLC $b eng $e rda $c DLC $d ERASA $d YDX $d OCLCO $d OCLCQ $d OCLCF $d UX0 $d UKMGB $d NDL $d BOL $d OCL $d NLVRD $d SILO 042 $a pcc 043 $a e------ $a e------ 050 00 $a K1519.D78 $b A94 2018 084 $a KN114.1.008 $b .A94 2018 $2 moys 100 1 $a Athanasiadou, Amalia, $e author. 245 10 $a Patent settlements in the pharmaceutical industry under US antitrust and EU competition law / $c Amalia Athanasiadou. 264 1 $a Alphen aan den Rijn, the Netherlands : $b Kluwer Law International B.V., $c [2018] 300 $a xxxi, 479 pages ; $c 25 cm. 490 1 $a International competition law series ; $v volume 75 504 $a Includes bibliographical references (pages 391-425) and index. 520 $a Patent Settlements in the Pharmaceutical Industry under US Antitrust and EU Competition Law examines patent settlements between originators and generic pharmaceutical manufacturers under United States (US) antitrust and European Union (EU) competition law. The major focus is on patent settlements involving reverse payments, commonly known as?pay-for-delay? settlements. Reverse payment settlements or?pay-for-delay agreements? create heated debates regarding the balance between competition and intellectual property law. These settlements touch upon sensitive issues such as timely generic entry and access to affordable pharmaceuticals on the one hand and the need to preserve innovation incentives for originators and to strengthen the pipeline of life-saving pharmaceuticals on the other hand. This book is one of the first to analyse critically and comparatively how such patent settlements and various other strategies employed by the pharmaceutical industry are scrutinised by US and European courts as well as enforcement authorities, focusing on the applicable legal tests and the main criteria used by courts and enforcement authorities when applying antitrust scrutiny. 540 $a Current Copyright Fee: GBP17.50 $c 0. $5 Uk 650 0 $a Pharmaceutical industry $x law and legislation $z United States. 650 0 $a Patent suits $z United States. 650 0 $a Antitrust law $z United States. 650 0 $a Pharmaceutical industry $x Law and legislation $z European Union countries. 650 0 $a Patent suits $z European Union countries. 650 0 $a Antitrust law $z European Union countries. 650 7 $a Antitrust law. $2 fast $0 (OCoLC)fst00810849 650 7 $a Patent suits. $2 fast $0 (OCoLC)fst01054860 650 7 $a Pharmaceutical industry $x Law and legislation. $2 fast $0 (OCoLC)fst01426221 651 7 $a European Union countries. $2 fast $0 (OCoLC)fst01269470 651 7 $a United States. $2 fast $0 (OCoLC)fst01204155 650 7 $a United States of America. $2 pplt 650 7 $a European Union. $2 pplt 650 7 $a Pharmaceuticals. $2 pplt 650 7 $a Patents. $2 pplt 650 7 $a Competition. $2 pplt 650 7 $a Intellectual property. $2 pplt 830 0 $a International competition law series ; $v v. 75. 941 $a 1 952 $l OVUX522 $d 20220526020250.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=5FEB261EE9E911EBBBC9467A3DECA4DBInitiate Another SILO Locator Search